50% off Premium Yearly

NASDAQ:SGEN
Seattle Genetics is a American stock, trading under the symbol SGEN (previously SGEN-Q on Stockchase) on the NASDAQ (SGEN). It is usually referred to as NASDAQ:SGEN or SGEN
In the last year, no analyst issued a Buy, Sell, or Hold rating on SGEN (previously SGEN-Q on Stockchase) on Stockchase. Read the latest expert commentary for Seattle Genetics.
Seattle Genetics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Seattle Genetics.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Seattle Genetics.
Seattle Genetics is followed by 7 investors on Stockchase and is a trending stock that is worth watching.
On 2023-12-13, Seattle Genetics (SGEN) stock closed at a price of $228.74.
They have antibody-based cancer treatments that he feels Gilead just overpaid for today in an acquisition. Merck announced it would take a $1 billion stake in SGEN. SGEN stock jumped from $150 Friday to $171 today. SGEN has stalled in recent months, but turns out this was undervalued.